Get started
Author

Karine Vigneault

Observed name: Vigneault, Karine
Institution: McGill University
ORCID: 0009-0002-1000-9474
Observed ORCID: 0009-0002-1000-9474
OpenAlex ID: A5098722964
Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs
2024 · Renata Iskander, Hannah Moyer, et al. · JAMA · 41
Early-phase trial efficacy and safety effect estimates regress upon testing in phase 3 trials
2026 · Angela Nelson, Hannah Moyer, et al. · Journal of Clinical Epidemiology · 2
Concordance of Efficacy and Safety in Phase Ib/Ii and Phase Iii Solid Tumour Treatment Trials
2025 · Angela Nelson, Hannah Moyer, et al. · SSRN Electronic Journal
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development
2024 · Hannah Moyer, Robyn Mellett, et al. · Neurology
PDF
Works count: 6
Citation count: 43
H-index: 2
I10-index: 1
Year
Topic
Type